VONLEROLIZUMAB
UNII C78148TF1D

Substance Identification & Data

This profile provides standardized clinical and technical data for Vonlerolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C78148TF1D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1638935-72-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C78148TF1D

CAS Registry Number

1638935-72-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VONLEROLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C121376

National Cancer Institute reference terminology for clinical and research data.

INN ID

10272

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-168

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vonlerolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

POGALIZUMAB

VONLEROLIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4(TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HUMANIZED MONOCLONAL ANTIBODY

VONLEROLIZUMAB [INN]

VONLEROLIZUMAB [USAN]

VONLEROLIZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 (ACT35 ANTIGEN, OX40L RECEPTOR, CD134 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED MOUSE VH (HOMO SAPIENS IGHV1-46*01 (81%) (IGHD)-IGHJ6*01 (92%)) (8.8.10) (1-117) -HOMO SAPIENS IGHG1*03 (CH1 R97>K(214)) (118-447)) (220-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED MOUSE V-KAPPA (HOMO SAPIENS IGKV1-39*01 (90%) IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')) DIMER (226-226'':229-229'')-BISDISULFIDE

SYS